Call for Abstracts: 12th International Conference on Cancer-Induced Bone Disease
15 to 17 November, 2012 Lyon, France
Abstract Submission Deadline: 2 July 2012
Call for Late-Breaking Abstracts: 1 August 2012
The International Meeting on Cancer-Induced Bone Disease is among the most exciting international occasions for the exchange of the latest scientific discoveries. They are designed to allow attendees to enhance their knowledge of diseases of the skeleton, basic bone biology, mineral metabolism, and their correlation to oncology.
Discussions on the latest advances in innovative treatments and cutting-edge practices await you at the 2012 event. The conference takes place 15-17 November 2012 in Lyon, France. The world’s leading scientists and researchers will be on-hand to share their expertise in bone metastases and bone and cancer cell biology.
Learning Objectives
The importance of both the physical and cellular bone microenvironment and the hematopoietic stem cell niche in supporting the growth of metastatic cancer cells
The role of cancer stem cells and hematopoietic stem cells in the metastatic process
The current state of the field of genomics and proteomics as applied to bone metastasis
The efficacy of new therapeutic agents and imaging techniques for bone cancers and bone metastasis
The consequences of tumor cells on the skeleton
Understanding of the mechanisms of therapy resistance
IBMS and CABS meetings are premier international scientific events that provide an international forum to present and discuss current basic and clinical science in the rapidly advancing field of skeletal complications of cancer.
International Bone and Mineral Society (IBMS)
401 N Michigan Ave Chicago, Suite 2200, IL 60611 USA
Phone: +1 312-321-5113 | Fax: +1 312-673-6934 | Email: info@ibmsonline.org





